NON SMALL LUNG CANCER
Clinical trials for NON SMALL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON SMALL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON SMALL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets tough lung cancer in 60-Patient trial
Disease control Recruiting nowThis study tests a new drug called SKB571 in 60 adults with advanced non-small cell lung cancer that has specific MET gene changes and has worsened after standard treatments. Participants receive SKB571 alone and are monitored for side effects and tumor shrinkage. The goal is to …
Matched conditions: NON SMALL LUNG CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 09:19 UTC
-
New hope for lung cancer: targeted pill takes on tough mutation
Disease control Recruiting nowThis study tests a drug called sotorasib as the first treatment for people with advanced non-small cell lung cancer that has a specific genetic change (KRAS G12C mutation). The goal is to see if the drug can shrink or control the cancer. About 39 adults who have not had any prior…
Matched conditions: NON SMALL LUNG CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:38 UTC